Drug Type Small molecule drug |
Synonyms INCB-186748 |
Target |
Action modulators |
Mechanism KRAS G12D modulators(GTPase KRas G12D modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Locally Advanced Malignant Solid Neoplasm | Phase 1 | United States | 27 Mar 2025 | |
| Metastatic Solid Tumor | Phase 1 | United States | 27 Mar 2025 |





